Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Injection in Reducing Scar Following Cheilorrhaphy
NCT07137234Completed
- Sponsor
- Mansoura University
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of botulinum toxin type A in unilateral cleft lip (UCL) (2 arms), sponsored by Mansoura University. Primary endpoint: Scar width at 6 months. Started Mar 2025; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
unilateral cleft lip (UCL)
Beyond the preview
Go deeper on NCT07137234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07137234.